Genetic enhancement of the Lis1+/- phenotype by a heterozygous mutation in the adenomatous polyposis coli gene.
| Autor: | Hebbar S; Department of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA., Guillotte AM, Mesngon MT, Zhou Q, Wynshaw-Boris A, Smith DS |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Developmental neuroscience [Dev Neurosci] 2008; Vol. 30 (1-3), pp. 157-70. |
| DOI: | 10.1159/000109860 |
| Abstrakt: | Hemizygous Lis1 mutations cause type 1 lissencephaly, a neuronal migration disorder in humans. The Lis1+/- mouse is a model for lissencephaly; mice exhibit neuronal migration defects but are viable and fertile. On an inbred genetic background, 20% of Lis1+/- mice develop hydrocephalus and die prematurely. Lis1 functions with the microtubule motor cytoplasmic dynein. Because dynactin, a dynein regulator, interacts with end-binding protein 1 (EB1) and beta-catenin, two known binding partners of the adenomatous polyposis coli (APC) protein, we looked for a genetic interaction between Lis1 and APC. Mice with a heterozygous truncating mutation in APC (Min mutation) do not exhibit neuronal migration defects or develop hydrocephalus. However, the presence of the APC mutation increases the migration deficit and the incidence of hydrocephalus in Lis1+/- animals. Lis1 and dynein distribution is altered in cells derived from Min mice, and both Lis1 and dynein interact with the C terminus of APC in vitro. Together, our findings point to a previously unknown interaction between APC and Lis1 during mammalian brain development. ((c) 2008 S. Karger AG, Basel.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|